Clinical Trial Update: Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating BZ371A in women with female sexual arousal disorder and female sexual dysfunction. The trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Arousal Disorder
• Female Sexual Dysfunction

Drugs mentioned

• BZ371A

Snippet

Sponsor: Biozeus Biopharmaceutical S.A. | Conditions: Female Sexual Arousal Disorder, Female Sexual Dysfunction | Phase 2 | Status: RECRUITING